Tetra Pharm Technologies ApS: Financial statements 2022
CVR: 40738223
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Tetra Pharm Technologies ApS (CVR 40738223) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -510,296 and a net result of DKK -7,767,688 compared with DKK 305,591 the year before. Equity in the 2022 report amounted to DKK 79,923,511. The solvency ratio was 93.7%. The company had 15 employees in the financial year.
- Gross Profit
- DKK -510,296
- Profit/Loss
- DKK -7,767,688
- Equity
- DKK 79,923,511
- Total Assets
- DKK 85,332,329
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -510K | -7.8M | 79.9M | 15 |
| 2021 | - | 3.2M | 306K | 9.9M | 6 |
Official annual report
Keep an eye on Tetra Pharm Technologies ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of August 1, 2022, OLE GS HOLDING ApS is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
Tetra Pharm Technologies ApS has published its annual report for 2021. Gross profit came to DKK 3,208,286, and the net result was DKK 305,591.
As of January 12, 2022, is registered as an owner of Tetra Pharm Technologies ApS with an ownership share of 5%.
About Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Rolf Sass Sørensen and Ulrich Wulff Norden Venge. The board consists of Søren Maarssø (chair), Claus Berner Nielsen, Jesper Breum and Rolf Sass Sørensen. The company's owners include RUMP INVEST ApS, Breum Holding EST. 2016 ApS and BrainFrame ApS. The company has 39 employees (2026). In 2025, the company reported a gross profit of DKK -17,669,007 and a net result of DKK -52,589,605 compared with DKK -55,213,708 the year before. Equity in the 2025 report amounted to DKK -25,844,292.